Pantoprazole sodium and Evening primrose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole sodium and Evening primrose. Common interactions include fall among females and c-reactive protein increased among males.

The phase IV clinical study analyzes what interactions people who take Pantoprazole sodium and Evening primrose have. It is created by eHealthMe based on reports of 18 people who take Pantoprazole sodium and Evening primrose from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

18 people who take Pantoprazole sodium and Evening primrose together, and have interactions are studied.

What is Pantoprazole sodium?

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 44,375 Pantoprazole sodium users for its effectiveness, alternative drugs and more.

What is Evening primrose?

Evening primrose has active ingredients of evening primrose oil. eHealthMe is studying from 1,564 Evening primrose users for its effectiveness, alternative drugs and more.

Number of Pantoprazole sodium and Evening primrose reports submitted per year:

Common Pantoprazole Sodium and Evening Primrose drug interactions by gender *:

female:

Fall
Contusion
Infusion site bruising
Malaise
Nausea
Upper limb fracture
Abdominal adhesions
Acute prerenal failure
Adverse event
Amblyopia

male:

C-reactive protein increased
Fatigue
Palpitations
Pulmonary hypertension
Sleep disorder
Supraventricular tachycardia
Urinary tract infection
Neuropathy peripheral
Platelet count decreased
Arthralgia

Common Pantoprazole Sodium and Evening Primrose drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

C-reactive protein increased
Contusion
Fall
Infusion site bruising
Upper limb fracture
Abdominal adhesions
Adverse event
Colon cancer stage iii
Deafness
Infection

60+:

Urinary tract infection
Arthralgia
Dyspepsia
Dyspnoea
Fatigue
Headache
Malaise
Malignant neoplasm progression
Neuropathy peripheral
Oxygen saturation decreased

Common conditions people have *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 22.22%
Type 2 Diabetes: 2 people, 11.11%
Hypersensitivity: 2 people, 11.11%
Immunodeficiency Common Variable: 2 people, 11.11%
Injection Site Inflammation: 2 people, 11.11%
Thyroid Cancer: 2 people, 11.11%
Multiple Myeloma (cancer of the plasma cells): 2 people, 11.11%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 11.11%
Pain: 2 people, 11.11%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole sodium and Evening primrose?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Min IS, Lee JY, Jung TS, Kang NK, Park BB, Kim BK, "Development of a Complete Atrioventricular Block Associated with Intake of Evening Primrose Oil", The Korean Journal of Medicine, 2016 May .